2021
Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors
Buza N. Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors. Seminars In Diagnostic Pathology 2021, 39: 58-77. PMID: 34750021, DOI: 10.1053/j.semdp.2021.10.006.Peer-Reviewed Original ResearchMeSH KeywordsCarcinomaFemaleGenital Neoplasms, FemaleHumansImmunohistochemistryWorld Health OrganizationConceptsGynecologic carcinomasOvarian carcinomaPathology evaluationLower genital tract carcinomaMismatch repair protein immunohistochemistryGenital tract carcinomaPD-L1 testingFemale genital tumorsLower genital tractSignificant prognostic differencesPrediction of prognosisRoutine pathology practiceClassification of tumorsMucinous adenocarcinomaPrognostic differencesEndometrial carcinomaHuman papillomavirusGenital tumorsProtein immunohistochemistryWHO classificationPrecursor lesionsGenital tractDiagnostic confirmationDifferential diagnosisImmunohistochemical markers
2018
Intra‐operative evaluation of prophylactic hysterectomy and salpingo‐oophorectomy specimens in hereditary gynaecological cancer syndromes
Wong S, Ratner E, Buza N. Intra‐operative evaluation of prophylactic hysterectomy and salpingo‐oophorectomy specimens in hereditary gynaecological cancer syndromes. Histopathology 2018, 73: 109-123. PMID: 29484698, DOI: 10.1111/his.13503.Peer-Reviewed Original ResearchConceptsIntra-operative evaluationTotal hysterectomyLynch syndromePermanent sectionsSalpingo-oophorectomy specimensFrozen section diagnosisGermline BRCA 1BrCa casesOccult malignancySurgical stagingProphylactic hysterectomyGynaecological malignanciesFinal diagnosisSecond surgeryGross findingsRetrospective analysisBRCA-1Cancer syndromesGross lesionsSection diagnosisDiagnostic discrepanciesFrozen sectionsMalignancyPractice recommendationsLS cases